|
|
|
15.01.26 - 02:27
|
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire EN)
|
|
|
ROCKVILLE, Md. and SUZHOU, China, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that its Chairman and CEO, Dajun Yang, M.D., Ph.D., presented at the 44th Annual J.P. Morgan Healthcare Conference. In the corporate presentation, Dr. Yang provided an overview of milestone achievements in 2025 and outlined the Company's global innovation strategy for 2026....
|
|
|
15.01.26 - 01:24
|
Aya Announces Board Transition and Secondary Market Transaction by Insiders (GlobeNewswire EN)
|
|
|
MONTREAL, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) today announced that two long-standing members of its Board of Directors, Robert Taub, Chair of the Board, and Dr. Jürgen Hambrecht, Lead Independent Director, will not stand for re-election at the Corporation's upcoming annual meeting, and will retire from the Board at the conclusion of their current terms....
|
|
|
15.01.26 - 01:03
|
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split (GlobeNewswire EN)
|
|
|
NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced the effective date of its 1-for-6.25 share consolidation (reverse stock split) of the Company's issued and outstanding common shares. At a Special Meeting of Stockholders held on April 16, 2025, shareholders approved a special resolution authorizing the Board of Directors, at any time prior to the next annual meeting of shareholders, to implement a share consolidation at a ratio of up to 1-for-50, with the exact timing and consolidation ratio to be determined in the Board's sole discretion. Following this approval, the Company's Board of Directors initially authorized a 1-for-7.97 consolidation ratio which was implemented Monday, May 5, 2025. On December 4, 2025, the board approved a second share consolidation at a ratio of 1-for-6.25....
|
|
|
15.01.26 - 00:03
|
Belo Sun Receives Ruling From Federal Court of Altamira, Para (GlobeNewswire EN)
|
|
|
TORONTO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX: BSX; OTCQB:BSXGF) announces that the Federal Court of Altamira, Pará, Brazil, denied the Company's request for recognition of provisional compliance with a prior judgment of the Federal Court of Appeals. That appellate judgment conditioned the effectiveness of the Construction License (Licença de Instalação – LI) for the Volta Grande Gold Project on (i) completion of the Indigenous Component Study based on primary data, and (ii) the conduct of prior, free, and informed consultation with the affected Indigenous communities....
|
|
|
|
|
|
|
|
|
14.01.26 - 23:15
|
Daktronics to Present at Sidoti Small-Cap Investor Conference (GlobeNewswire EN)
|
|
|
BROOKINGS, S.D., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Daktronics Inc. (Nasdaq: DAKT), a leading global designer and manufacturer of best-in-class dynamic video communication displays and control systems for customers worldwide, announced that management will present and host one-on-one meetings with investors at Sidoti's Micro-Cap Virtual Investor Conference, taking place on January 22, 2026....
|
|
|
14.01.26 - 23:06
|
Enerflex Ltd. Announces Timing of Fourth Quarter Financial and Operational Results (GlobeNewswire EN)
|
|
|
CALGARY, Alberta, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) plans to release its financial results and operating highlights for the year ended December 31, 2025, on Thursday, February 26, 2026 prior to market open. Results will be communicated by news release and will be available on the Company's website at www.enerflex.com and under the electronic profile of the Company on SEDAR+ and EDGAR at www.sedarplus.ca and www.sec.gov/edgar, respectively....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.01.26 - 22:18
|
Plexus Sets Fiscal First Quarter 2026 Earnings Release Date (GlobeNewswire EN)
|
|
|
NEENAH, WI, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) announced today it will release its fiscal first quarter 2026 results after market close on Wednesday, January 28, 2026. Plexus' management will host a conference call to discuss its fiscal first quarter 2026 results on Thursday, January 29, 2026 at 8:30 a.m. Eastern Time. An audio webcast of the call and accompanying slides will be available in the investor relations section of the company website, plexus.com....
|
|
|
14.01.26 - 22:18
|
Antelope Enterprise Holdings Limited Receives NASDAQ Notice Related to Late Filing of Its Interim Report (GlobeNewswire EN)
|
|
|
New York, NY, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Antelope Enterprise Holdings Limited (NASDAQ: AEHL, or the “Company”), today announced that today announced that it has received a letter from the Nasdaq Stock Market, dated January 12, 2026 (the “Delinquency Letter”), notifying the Company that it is not in compliance with the requirements for continued listing set forth in NASDAQ Listing Rule 5250(c)(1) because it did not timely file its interim report on Form 6-K containing an interim balance sheet and income statement for its fiscal half year ended June 30, 2025 (the “2025 Interim Report”), it no longer complies with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires that listed companies timely file all required periodic financial reports with the Securities and Exchange Commission. In accordance with Nasdaq Listing Rules, the Company has 60 calendar days from the date of the Delinquency Letter to submit a plan to regain compliance with the Rule (the “Compliance Plan”). If...
|
|